Baxter International (BAX)
(Delayed Data from NYSE)
$21.96 USD
+0.20 (0.92%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $22.15 +0.19 (0.87%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Baxter International Inc. has a market cap of $11.17B, which represents its share price of $21.76 multiplied by its outstanding shares number of 513.17M. As a large-cap company, BAX's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BAX 21.96 +0.20(0.92%)
Will BAX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BAX
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
BAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
InMode (INMD) Q2 Earnings and Revenues Beat Estimates
Other News for BAX
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Trump imposes new tariffs, Apple reports Q3 beat: Morning Buzz
Significant Option Activity in Baxter (BAX) Drives Market Interest
BAX: Wells Fargo Lowers Price Target to $24, Maintains Equal-Weight Rating | BAX Stock News
Avis Budget downgraded, Sprouts upgraded: Wall Street's top analyst calls